Corporate Banner
Satellite Banner
Technology Networks Header
Friday, August 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Autoscribe Adds New QC Automation Capabilities Added To Matrix Gemini LIMS
Tuesday, February 25, 2014
Enhancement includes the addition of a facility for the automation of quality control samples

Sapio Sciences Announces Exemplar LIMS for Clinical and Research NGS Labs
Tuesday, February 25, 2014
Purpose-built system handles the sample tracking and processing needs of clinical or research laboratories

Agilent Technologies Expands Next-Generation Sequencing Target-Enrichment Platform with SureCall Software Upgrade
Saturday, February 15, 2014
Clinical Researchers Can Now Easily Transform Raw NGS Data into Insightful Analyses

Paragon Backup & Recovery 14 Home – Safeguarding the Data on Your Modern or Old-School Windows PC
Tuesday, February 11, 2014

New LIMS Software for Toxicology Labs
Tuesday, February 11, 2014
Cloud-based LIMS solution will handle all of the tasks necessary for running and maintaining an efficient and state-of-the-art toxicology laboratory.

ScienceCloud by Accelrys Transforms Externalized Drug Discovery
Tuesday, February 11, 2014
New cloud solution for externalized life science research and development redefines collaboration and creativity

Cloudera Delivers First Complete Enterprise Data Hub
Friday, February 07, 2014
Cloudera Enterprise provides a single platform that complements existing systems to efficiently and securely store, process, analyze and serve any amount or type of data.

Common Cents Systems and Translational Software Improve Efficiency in Pharmacogenetic Testing
Tuesday, February 04, 2014
The collaboration combines Apollo’s platform for operational excellence with Translational Software’s PGx decision support system.

Bruker CAM Launches Bruker Dash Reporting, the Next Step in Intuitive Customized Reporting
Monday, February 03, 2014

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 357
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv